The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A

被引:0
作者
Christian Faul
Mary Donnelly
Sandra Merscher-Gomez
Yoon Hee Chang
Stefan Franz
Jacqueline Delfgaauw
Jer-Ming Chang
Hoon Young Choi
Kirk N Campbell
Kwanghee Kim
Jochen Reiser
Peter Mundel
机构
[1] University of Miami Miller School of Medicine,Department of Medicine
[2] Mount Sinai School of Medicine,Department of Medicine
[3] One Gustave L. Levy Place,Department of Internal Medicine
[4] Hsiao-Kang Municipal Hospital,Nephrology Division and Program in Glomerular Disease, Department of Medicine
[5] Kaohsiung,undefined
[6] Medical University,undefined
[7] Massachusetts General Hospital,undefined
[8] Harvard Medical School,undefined
[9] Present addresses: Department of Medicine,undefined
[10] Yale New Haven Hospital,undefined
[11] 20 York Street,undefined
[12] New Haven,undefined
[13] Connecticut 06510,undefined
[14] USA (Y.H.C.); Roche Pharma Switzerland,undefined
[15] Schönmattstrasse 2,undefined
[16] CH-4153 Reinach,undefined
[17] Switzerland (S.F.); Development Science,undefined
[18] Grünenthal,undefined
[19] Ziegelstrasse,undefined
[20] D-52078 Aachen,undefined
[21] Germany (J.D.).,undefined
来源
Nature Medicine | 2008年 / 14卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Currently, there are few options for treating chronic kidney disease. The immunosuppressant cyclosporine A is effective, but the mechanism has been unclear. In this new report, the authors now show that the benefit of cyclosporine A is not through an effect on the immune system but rather through stabilizing the cytoskeleton, and thus the integrity, of a key cell type needed for proper kidney function.
引用
收藏
页码:931 / 938
页数:7
相关论文
共 75 条
[11]  
Yanagida-Asanuma E(2002)NFAT signaling: choreographing the social lives of cells Cell 109 S67-S79
[12]  
Kim K(2006)Calcineurin-NFAT signalling regulates pancreatic beta cell growth and function Nature 443 345-349
[13]  
Mundel P(2008)NFATc1 balances quiescence and proliferation of skin stem cells Cell 132 299-310
[14]  
Mundel P(2005)NFAT and Osterix cooperatively regulate bone formation Nat. Med. 11 880-885
[15]  
Asanuma K(2005)Treatment of focal segmental glomerulosclerosis Expert Opin. Pharmacother. 6 1539-1549
[16]  
Huber TB(2007)Cyclosporin therapy in patients with Alport syndrome Pediatr. Nephrol. 22 57-63
[17]  
Asanuma K(2003)Cyclosporine A slows the progressive renal disease of alport syndrome (X-linked hereditary nephritis): results from a canine model J. Am. Soc. Nephrol. 14 690-698
[18]  
Yanagida-Asanuma E(2004)Induction of B7–1 in podocytes is associated with nephrotic syndrome J. Clin. Invest. 113 1390-1397
[19]  
Aramburu J(2000)14-3-3 proteins: structure, function and regulation Annu. Rev. Pharmacol. Toxicol. 40 617-647
[20]  
Heitman J(1997)The structural basis for 14-3-3–phosphopeptide binding specificity Cell 91 961-971